FRANCIOTTA, DIEGO
 Distribuzione geografica
Continente #
NA - Nord America 1.420
EU - Europa 891
AS - Asia 865
SA - Sud America 138
AF - Africa 20
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.338
Nazione #
US - Stati Uniti d'America 1.383
CN - Cina 356
SG - Singapore 261
IE - Irlanda 220
RU - Federazione Russa 163
DE - Germania 122
HK - Hong Kong 122
BR - Brasile 111
FI - Finlandia 111
IT - Italia 85
VN - Vietnam 47
GB - Regno Unito 44
IN - India 27
UA - Ucraina 22
ES - Italia 20
CA - Canada 19
BE - Belgio 17
JP - Giappone 15
MX - Messico 13
AR - Argentina 12
AT - Austria 12
FR - Francia 12
PL - Polonia 12
CZ - Repubblica Ceca 11
SE - Svezia 11
MA - Marocco 7
ZA - Sudafrica 7
BD - Bangladesh 6
EC - Ecuador 5
IQ - Iraq 5
NL - Olanda 5
IR - Iran 4
LT - Lituania 4
PK - Pakistan 4
PT - Portogallo 4
PY - Paraguay 4
TR - Turchia 4
AL - Albania 2
CH - Svizzera 2
CO - Colombia 2
DO - Repubblica Dominicana 2
ID - Indonesia 2
JO - Giordania 2
KE - Kenya 2
MD - Moldavia 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
SA - Arabia Saudita 2
VE - Venezuela 2
AU - Australia 1
BG - Bulgaria 1
BO - Bolivia 1
CI - Costa d'Avorio 1
CW - ???statistics.table.value.countryCode.CW??? 1
DK - Danimarca 1
DZ - Algeria 1
HU - Ungheria 1
IL - Israele 1
IS - Islanda 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LU - Lussemburgo 1
LV - Lettonia 1
MY - Malesia 1
NO - Norvegia 1
NP - Nepal 1
PA - Panama 1
PE - Perù 1
QA - Qatar 1
RO - Romania 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
TG - Togo 1
TN - Tunisia 1
UZ - Uzbekistan 1
Totale 3.338
Città #
Dublin 220
Chandler 219
Ashburn 170
Singapore 152
Dallas 133
Hong Kong 122
Beijing 89
Helsinki 70
Boardman 66
Munich 63
Los Angeles 54
Jacksonville 47
New York 42
Nanjing 40
Moscow 33
Lawrence 31
Princeton 31
Medford 26
Shanghai 24
Wilmington 24
Ho Chi Minh City 21
Redondo Beach 21
Shenyang 21
Ann Arbor 20
Nanchang 20
Turku 20
Buffalo 18
Brussels 17
São Paulo 17
Tokyo 15
Rome 14
Hebei 13
Montreal 13
Jiaxing 12
Changsha 11
Hanoi 11
Brooklyn 10
Milan 10
Pune 10
Brno 9
London 9
San Francisco 9
Santa Clara 9
Seattle 9
Chicago 8
Stockholm 8
Warsaw 8
Düsseldorf 7
Falkenstein 7
Frankfurt am Main 7
Houston 7
Manchester 7
Tianjin 7
Denver 6
Fairfield 6
Madrid 6
Nuremberg 6
Orem 6
Pavia 6
Woodbridge 6
Atlanta 5
Guangzhou 5
Hangzhou 5
Poplar 5
Asunción 4
Bologna 4
Boston 4
Mexico City 4
New Delhi 4
Piscataway 4
Secaucus 4
The Dalles 4
Verona 4
Berlin 3
Cambridge 3
Cape Town 3
Casablanca 3
Changchun 3
Chennai 3
Dearborn 3
Florence 3
Fortaleza 3
Hefei 3
Hyderabad 3
Jinan 3
Johannesburg 3
Milwaukee 3
Mumbai 3
Phoenix 3
Rio de Janeiro 3
San Jose 3
Seveso 3
Washington 3
Xi'an 3
'Asir Region 2
Annapolis 2
Auckland 2
Baghdad 2
Belo Horizonte 2
Changzhou 2
Totale 2.234
Nome #
Combined central and peripheral demyelination: Clinical features, diagnostic findings, and treatment 145
Meningeal melanomatosis: a challenge for timely diagnosis. 118
Cell-cycle inhibition by Helicobacter pylori L-asparaginase. 115
Inverse association between multiple sclerosis and respiratory allergic diseases 112
Predictors of outcome in a large retrospective cohort of patients with transverse myelitis 110
Late post-transplant anti-aquaporin-4 Ab-positive optic neuritis in a patient with AML 107
Correlation of frontal atrophy and CSF tau levels with neuropsychiatric symptoms in patients with cognitive impairment: a memory clinic experience 105
Conventional brain MRI features distinguishing limbic encephalitis from mesial temporal glioma 102
Antibodies to neurofascin, contactin-1, and contactin-associated protein 1 in CIDP: Clinical relevance of IgG isotype 102
Diagnostics of anti-MAG antibody polyneuropathy 99
Air pollution as a contributor to the inflammatory activity of multiple sclerosis 98
COVID-19 and Guillain–Barré Syndrome: A Case Report and Review of Literature 97
Diagnostics of dysimmune peripheral neuropathies 96
Lack of antibodies to neuropil antigens in idiopathic REM sleep behavior disorder 93
Cranial nerve palsies in patients with hematological malignancies: a case series 92
Guillain-Barré syndrome associated with SARS-CoV-2 91
Antibodies to neuronal surface antigens in patients with a clinical diagnosis of neurodegenerative disorder 90
Devic's neuromyelitis optica: long-term follow-up and serial CSF findings in two cases. 84
Gender difference and autoimmune disease: a study of polymorphic MHC genomic markers in myasthenia gravis (MG) 84
Ambroxol as a disease-modifying treatment to reduce the risk of cognitive impairment in GBA-associated Parkinson's disease: a multicentre, randomised, double-blind, placebo-controlled, phase II trial. The AMBITIOUS study protocol 81
Absence of pathogenic mutations in CD59 in chronic inflammatory demyelinating polyradiculoneuropathy 81
Measurement of skeletal muscle mass in Duchenne muscular disease: usefulness of 24-hour creatinine excretion 79
COVID-19 in patients with Myasthenia Gravis: epidemiology and disease course 78
Primary central nervous system lymphoma mimicking autoimmune encephalitis: the role of autoantibody testing 75
Genetic basis for idiosyncratic reactions to antiepileptic drugs. 74
Retrograde Amnesia in LGI1 and CASPR2 Limbic Encephalitis: Two Case Reports and a Systematic Literature Review 71
Ceftazidime/avibactam neurotoxicity in an adult patient with normal renal function 71
Correction: Absence of pathogenic mutations in CD59 in chronic inflammatory demyelinating polyradiculoneuropathy (PLoS ONE (2019) 14: 2 (e0212647) DOI: 10.1371/journal.pone.0212647) 68
Clinical, prognostic and pathophysiological implications of MOG-IgG detection in the CSF: the importance of intrathecal MOG-IgG synthesis 66
Remarkable Rituximab Response on Tremor Related to Acute-Onset Chronic Inflammatory Demyelinating Polyradiculoneuropathy in an Antineurofascin155 Immunoglobulin G4–Seropositive Patient 65
Polymorphic markers in MHC class II/III region: a study on Italian patients with myastenia gravis 58
Immunohistochemical characterization of a new atypic antibody in a paraneoplastic neurological syndromes. 56
Role of Cerebrospinal Fluid Biomarkers and (18)F-florbetapir PET Imaging in the Diagnosis of Primary Progressive Aphasia: A Retrospective Analysis 56
Hodgkin Lymphoma With Diplopia and Nystagmus: A Paraneoplastic Cerebellar Degeneration With Ectopic Expression of DNER Antigen on Reed-Sternberg Cells 50
Conformational Antibodies to Proteolipid Protein-1 and Its Peripheral Isoform DM20 in Patients With CNS Autoimmune Demyelinating Disorders 49
MOG-IgG testing strategies in accordance with the 2023 MOGAD criteria: a clinical-laboratory assessment 49
Improving laboratory diagnostics in myasthenia gravis 47
Visual System Involvement in Glial Fibrillary Acidic Protein Astrocytopathy 47
Comparison of Fixed and Live Cell-Based Assay for the Detection of AChR and MuSK Antibodies in Myasthenia Gravis 45
Prognostic relevance of quantitative and longitudinal MOG antibody testing in patients with MOGAD: a multicentre retrospective study 44
General features, pathogenesis, and laboratory diagnostics of autoimmune encephalitis 39
Paraneoplastic Neurological Syndromes: Transitioning Between the Old and the New 37
Impact of seizures and their prophylaxis with antiepileptic drugs on rehabilitation course of patients with traumatic or hemorrhagic brain injury 37
null 21
Thyroid function in the subacute phase of traumatic brain injury: a potential predictor of post-traumatic neurological and functional outcomes 17
Totale 3.401
Categoria #
all - tutte 15.186
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.186


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202170 0 0 0 0 0 8 2 32 7 11 5 5
2021/2022148 5 1 3 2 5 4 3 7 12 3 21 82
2022/2023614 56 56 4 58 41 60 0 27 270 10 24 8
2023/2024314 33 45 3 20 14 77 12 36 0 14 14 46
2024/2025912 44 48 41 19 30 68 48 36 234 51 86 207
2025/20261.057 141 114 188 271 275 68 0 0 0 0 0 0
Totale 3.401